CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Nintedanib Capsules Approval and Launch

NDA FilingapprovedNintedanib CapsulesPositive
AI Analysis

Summary

Dexcel Pharma USA received FDA approval for its ANDA for generic Nintedanib Capsules (100 mg and 150 mg). The company announced its intent to launch the generic equivalent.

Outcome Details

FDA approval of ANDA for Nintedanib Capsules, 100 mg and 150 mg

Importance:6/10
Sentiment:
0.80
FDA approvalgeneric drugANDANintedanib

Read the original article

Published by PR Newswire Pharma on April 7, 2026 8:11 PM

Read Original